Literature DB >> 11104868

Differential expression of three types of nitric oxide synthase in both infarcted and non-infarcted left ventricles after myocardial infarction in the rat.

Y Takimoto1, T Aoyama, R Keyamura, E Shinoda, R Hattori, Y Yui, S Sasayama.   

Abstract

In the present report we investigated the differential expression of three types of nitric oxide synthase (NOS) in the left ventricle after myocardial infarction in rats. One, 3, 7, 14, 28 and 56 days (n=6-12 for each group) after ligation of a coronary artery, tissue samples were obtained from infarcted and non-infarcted tissues. The mRNA and protein levels of neuronal (n) NOS, endothelial (e) NOS and inducible (i) NOS were sequentially determined by semi-quantitative reverse transcription-polymerase chain reaction and Western blotting. Progressive left ventricular dilatation and gradual reduction in fractional shortening were confirmed by echocardiography. The expression levels of nNOS were significantly increased 1, 3 and 7 days post-infarct compared to those of sham-operated rats in both the infarcted (P<0.01) and non-infarcted regions (P<0.01). Immunohistochemical analysis showed that nNOS was localized in nerve fibers in the left ventricle and that the number of positive fibers after myocardial infarction had increased compared to that in sham-operated rats. With regard to eNOS, no significant changes in expression levels were detected between infarcted hearts and sham-operated controls. The level of iNOS expression peaked three days post-infarct and then decreased in the infarcted tissue, whereas it increased one day post-infarct, peaked at 14 and 28 days post-infarct and was still elevated in the chronic stage in the ventricular septum. iNOS immunoreactivity was detected in spared cardiomyocytes and macrophages in the infarcted region, and in cardiomyocytes in the ventricular septum. The expressions of three types of NOS were differentially regulated and iNOS produced in the non-infarcted region may contribute to the progression of heart failure after myocardial infarction in rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11104868     DOI: 10.1016/s0167-5273(00)00394-6

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  Neuronal nitric oxide synthase (NOS) regulates leukocyte-endothelial cell interactions in endothelial NOS deficient mice.

Authors:  M J Sanz; M J Hickey; B Johnston; D M McCafferty; E Raharjo; P L Huang; P Kubes
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

2.  Leukocyte iNOS is required for inflammation and pathological remodeling in ischemic heart failure.

Authors:  Justin R Kingery; Tariq Hamid; Robert K Lewis; Mohamed Ameen Ismahil; Shyam S Bansal; Gregg Rokosh; Tim M Townes; Suzanne T Ildstad; Steven P Jones; Sumanth D Prabhu
Journal:  Basic Res Cardiol       Date:  2017-02-25       Impact factor: 17.165

Review 3.  Myocardial repair/remodelling following infarction: roles of local factors.

Authors:  Yao Sun
Journal:  Cardiovasc Res       Date:  2008-12-02       Impact factor: 10.787

4.  Dual role of nNOS in ischemic injury and preconditioning.

Authors:  Anupama Barua; Nicholas B Standen; Manuel Galiñanes
Journal:  BMC Physiol       Date:  2010-08-13

Review 5.  Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component?

Authors:  Claire E Sears; Euan A Ashley; Barbara Casadei
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

Review 6.  The therapeutic effect of natriuretic peptides in heart failure; differential regulation of endothelial and inducible nitric oxide synthases.

Authors:  Angelino Calderone
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

7.  The role of S-methylisothiourea hemisulfate as inducible nitric oxide synthase inhibitor against kidney iron deposition in iron overload rats.

Authors:  Maryam Maleki; Melika Samadi; Mehrangiz Khanmoradi; Mehdi Nematbakhsh; Ardeshir Talebi; Hamid Nasri
Journal:  Adv Biomed Res       Date:  2016-05-30

Review 8.  Nitric oxide in the cardiovascular system: a simple molecule with complex actions.

Authors:  Hans Strijdom; Nontuthuko Chamane; Amanda Lochner
Journal:  Cardiovasc J Afr       Date:  2009 Sep-Oct       Impact factor: 1.167

9.  Natakalim improves post-infarction left ventricular remodeling by restoring the coordinated balance between endothelial function and cardiac hypertrophy.

Authors:  Hong-Min Zhou; Ming-Li Zhong; Yan-Fang Zhang; Wen-Yu Cui; Chao-Liang Long; Hai Wang
Journal:  Int J Mol Med       Date:  2014-09-12       Impact factor: 4.101

10.  Changes in gene expression patterns in postmortem human myocardial infarction.

Authors:  Verena Wilmes; Constantin Lux; Constanze Niess; Elise Gradhand; Marcel A Verhoff; Silke Kauferstein
Journal:  Int J Legal Med       Date:  2020-05-12       Impact factor: 2.686

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.